Logo of jkmsThis ArticleThis JournalJKMS Journal of Korean Medical ScienceAboutFor Contributorse-Submission
J Korean Med Sci. Dec 2005; 20(6): 1089–1092.
Published online Dec 31, 2005. doi:  10.3346/jkms.2005.20.6.1089
PMCID: PMC2779318

GSTM1, GSTT1 and GSTP1 Polymorphisms in the Korean Population

Abstract

The isoenzymes of the glutathione s transferase (GST) family play a vital role in phase II of biotransformation of many substances. Using a multiplex polymerase chain reaction and a direct sequencing analysis, the frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms were evaluated in 1,051 Korean male subjects. We found that 53.8% of the individuals had the GSTM1 null genotype and 54.3% had the GSTT 1 null genotype. The genotypic distribution of GSTP1 was Ile105/Ile105 in 68.4%, Ile105/Val105 in 29.1% and Val105/Val105 in 2.5%. The most frequently observed combination of GSTM1, GSTP1 and GSTT1 genotypes was Null type/Ile105/Ile105/Null type, while the combination of Non-null type/Val105/Val105/Non-Null type was not observed. We found that the genotype distributions of three GST isoenzymes in the Koreans are similar to those reported in Asians and previously reported Koreans. We believe our results, which are represented by a large population, are reliable estimates of the frequencies of the polymorphic GST alleles in the Koreans and will help future researches on GST polymorphisms.

Keywords: Glutathione Transferase, glutathione S-transferase pi, glutathione transferase TI-1, human, GST, Polymorphism, Genetic, Korea

Glutathione s transferases (GSTs) consist of a superfamily of dimeric phase II metabolic enzymes that catalyse the conjugation of reduced glutathione with various electrophilic compounds (1). The human GST genes are divided into four major subfamilies designated as GSTα or A, GSTµ or M, GSTθ or T, and GSTπ or P (2). The class πGST gene exists as a single functional gene in human, whereas class α, µ, and θ families contain multiple distinct genes, sharing ~55, 65, and 50% identity, respectively (3). Two of these subfamilies, GSTM1 and GSTT1, show deletion polymorphism (4), and the GSTP1 gene has polymorphism loci within its coding region, of which well-known are an A- to -G transition at nucleotide position 1,578 causing an isoleucine-to-valine substitution at codon 105 (Ile105Val) in exon 5, a C- to -T base change at position 2,293 giving rise to the replacement of alanine to valine at the amino acid position 114 (Ala114Val) in exon 6 (5, 6).

Human cytosolic GSTs have been well characterized and known to be polymorphic, with different polymorphism frequencies by ethnicity. The percentage of individuals who do not express the GSTM1 enzyme due to a homozygous gene deletion is higher in Caucasians and Asians than in Africans (7, 8). About 60% of Asians, 40% of Africans and 20% of Caucasians do not express the GSTT1 enzyme (9). These homozygous gene deletions, called null genotypes, are denoted as GSTM1*0/*0 and GSTT1*0/*0. Polymorphisms of GSTM1, GSTT1, and GSTP1 have been shown to be associated with susceptibility to various forms of cancer, particular those caused by cigarette smoking (9), resistance to chemotherapy treatment (3), and disease outcomes (10). We analyzed the frequencies of the major polymorphisms of GSTM1, GSTT1 and GSTP1 in a Korean male population to provide a basic database for future clinical and genetic studies concerning variability in the response and/or toxicity to drugs known to be substrates for GSTs.

The study subjects are healthy individuals recruited from the health promotion center, Samsung Medical Center without any pathology. A total of 1,051 unrelated male Korean subjects (mean age, 50.7 yr; range, 35-76 yr) participated in this study. Deletion status of GSTM1 and GSTT1 was simultaneously determined by a multiplex polymerase chain reaction method (11). GSTM1 and GSTT1 genes were amplified using the following primers: 5'GAA CTC CCT GAA AAG CTA AAG C 3'and 5'GTT GGG CTC AAA TAT ACG GTG G 3'for GSTM1 and 5'TTC CTT ACT GGT CCT CAC ATC TC 3'and 5'TCA CCG GAT CAT GGC CAG CA 3'for GSTT1. As an internal control, exon 7 of the CYP1A1 gene was co-amplified using the primers 5'GAA CTG CCA GGC CAG CA 3'and 5'CAG CTG CAT TTG GAA GTG CTC 3'. Agarose gel electrophoresis (1%) resolved amplified DNA fragments of 480, 312, and 215 bp for GSTT1, CYP1A1 and GSTM1, respectively. To determine the genotypes at codon 105 and 114, respectively, the exon 5 and exon 6 of the GSTP1 gene were amplified using the following primers: 5'TGT GTG GCA GTC TCT CAT CC 3'and 5'GAA GCC CCT TTC TTG TTC A 3'for the exon 5 and 5'GCAAGCAGAGGAGAA TCT GG 3'and 5'CTA AGC CCA TCC CCT AGG TC 3'for the exon 6, and directly sequenced on ABI Prism 3,700 Genetic analyzer (Applied Biosystems, Foster City, CA, U.S.A.) using the ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction kit (Applied Biosystems).

The null GSTM1 and GSTT1 genotypes were found in 53.8% and 54.3% of the individuals, respectively. Twenty-nine percent had the null genotype for both genes. The only genetic polymorphism in GSTP1 was Ile105Val in exon 5. The genotype distribution of this locus was Ile105/Ile105 in 68.4%, Ile105/Val105 in 29.1%, and Val105/Val105 in 2.5%, which is in Hardy-Weinberg equilibrium by χ2 test. The allele frequency of Ile at codon 105 was 0.83. We examined the distribution and frequencies of the combined genotypes of GSTM1, GSTP1 and GSTM1. For genotype combination analysis, there were 1,021 samples available where the genotyping was successful for each of three GST genes. Eleven out of 12 possible combinations were observed (Table 1). Five genotype combinations showed frequencies greater than 10%. The most frequently observed combination was Null type/Ile105/Ile105/Null type, while Non-null type/Val105/Val105/Non-Null type was not observed.

Table 1
Frequency distribution of the combined genotypes for the GSTM1, GSTT1 and GSTP1 polymorphism

Polymorphisms in GST genes can affect the expression levels of the GST enzymes. Since GST enzymes play a vital role in cellular defense against environmentally toxic compounds, such as carcinogens, polymorphisms of GST gene can increase subsceptibility to diseases caused by such xenobiotics. We observed 53.8% of the Korean population were homozygous for the GSTM1 deletion. This frequency is similar to that reported in a previous study that analyzed the GSTM1 polymorphism in Koreans (12, 13) and also to those reported in other studies in Caucasians and Japanese (Table 2) (14, 15). We observed 54.3% of these Koreans were homozygous for the GSTT1 deletion. This frequency is similar to that reported in other studies that analyzed the GSTT1 polymorphism in Koreans and Japanese (12, 15), however higher than that observed in Caucasian population (Table 2) (7, 14, 16). The frequency of double nulls observed in the present study (29.1%) is higher than that observed in a Caucasian population (14), South Indians, and Afro-Americans (17). No frequency data are available for double nulls in other Asians including Japanese and Chinese, and Koreans. Three different GSTP1 alleles, GSTP1a, GSTP1b, and GSTP1c, have been described (6). GSTP1b differs from GSTP1a by having an A→G transition at nucleotide +313, changing codon 105 from ATG (Ile) to GTC (Val). GSTP1c is characterized by two nucleotide transitions, A→G at +313, the same as observed in GSTP1b, and C→T at +341, changing codon 114 from GCG (Ala) to GTG (Val) (5). In this study, we observed 68.4% had the Ile105/Ile105 genotype, 29.1% had the Ile105/Val105 genotype, and 2.5% had the Val105/Val105 genotype, with an allelic frequency 0.83 for the Ile allele. The polymorphism GCG (Ala)→GTG (Val) at codon 114 was not observed. These results are similar to those reported in other studies in Koreans (18) and other Asians (19, 20). The Val105/Val105 genotype was more frequent in Caucasians than in Asians (Table 3) (21). Little has been known about the combined effect of the GSTM1, GSTT1, and GSTP1 genotypes. For all three polymorphisms, previous studies reported association with various diseases, however subsequent studies validating these findings are lacking. Recent reports and meta-analysis show that single GST gene polymorphisms do not significantly increase risks to various diseases (22-24), suggesting investigations on combined genotypes of GSTM1, GSTT1 and GSTP1, or even in relation to other metabolizing enzymes are needed. Several studies have reported a relationship between combination of the GST genotype and risk of various diseases such as chronic lymphocytic leukemia, thyroid cancer and breast cancer (25-27) and some of them suggested a possible synergistic effect between GST genotypes (25, 27). In present study concerning combination of the GSTM1, GSTP1 and GSTT1 genotypes, noteworthy points are lack of Non-null type/Val105/Val105/Non-Null type and presence of Null type/Val105/Val105/Null type. Although finding might need further confirmation in other healthy populations, it suggests a potential difference in genetic susceptibility to various diseases in Korean population. Although our study included only male subjects, given that the genotype frequencies are not affected by sex in general (28), our data can represent the population genotype frequencies. Indeed, our data did not show any significant differences when compared with other studies that included female subjects (13, 28).

Table 2
Frequencies of the homozygous deletions at GSTM1, GSTT1 loci and their combination in present study, in comparison with those on other studies in Koreans and other populations
Table 3
Frequencies of GSTP1 polymorphisms in the present study, in comparison those in other studies on Koreans and other populations

In conclusion, genotype data for polymorphic variants of GST genes provide further evidence for ethnic variations in metabolism and disposition. The notable merit of this study is that we genotyped all three major GST enzymes, GSTM1, GSTP1, and GSTT1, in the largest population studied, reporting the frequency distribution of the combined genotypes. We believe these data will help genetic studies on GSTM1, GSTT1 and GSTP1 polymorphisms in association with disease risks and drug effects in Koreans.

Footnotes

This study was supported by a grant of the Korea Health 21 R & D Project, Ministry of Health & Welfare, R.O.K (03-PJ10-PG13-GD01-0002).

References

1. Mannervik B. The isoenzymes of glutathione transferase. Adv Enzymol Relat Areas Mol Biol. 1985;57:357–417. [PubMed]
2. Mannervik B, Awasthi YC, Board PG, Hayes JD, Di Ilio C, Ketterer B, Listowsky I, Morgenstern R, Muramatsu M, Pearson WR. Nomenclature for human glutathione transferases. Biochem J. 1992;282:305–306. [PMC free article] [PubMed]
3. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445–600. [PubMed]
4. Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo ZF, Schwartz BS. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis. 1995;16:1243–1245. [PubMed]
5. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997;272:10004–10012. [PubMed]
6. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 1997;18:641–644. [PubMed]
7. Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF. Breast cancer and CYP1A1, GSTM1, and GSTT1 polymorphism: evidence of a lack of association in Caucasians and African Americans. Cancer Res. 1998;58:65–70. [PubMed]
8. Roth MJ, Dawsey SM, Wang G, Tangrea JA, Zhou B, Ratnasinghe D, Woodson KG, Olivero OA, Poierier MC, Frye BL, Taylor PR, Weston A. Association between GSTM1*0 and squamous dysplasia of the esophagus in the high risk region of Linxian, China. Cancer Lett. 2000;156:73–81. [PubMed]
9. Strange RC, Fryer AA. The glutathione S-transferase: influence of polymorphism on cancer susceptibility. In: Vineis P, editor. Metabolic polymorphism and susceptibility to cancer. Lyon France: IARC Scientific Publication; 1999. pp. 231–249.
10. Lear JY, Heagerty AH, Smith A, Bowers B, Payne CR, Smith CA, Jones PW, Gilford J, Yengi L, Alldersea J, Fryer AA, Strange RC. Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumor numbers and accrual. Carcinogenesis. 1996;12:1891–1896. [PubMed]
11. Abdel-Rahman SZ, El-Zein RA, Anwar WA, Au WW. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett. 1996;107:229–233. [PubMed]
12. Choi SC, Yun KJ, Kim TH, Kim HJ, Park SG, Oh GJ, Chae SC, Nah YH, Kim JJ, Chung HT. Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression. Cancer Letters. 2003;195:169–175. [PubMed]
13. Jang SS, Jung CY, Lee SY, Lee JH, Jeon HS, Park SH, Son JW, Lee EB, Kim CH, Kam S, Park RW, Kim IS, Jung TH, Park JY. The GST1 genotypes as a marker for susceptibility to lung cancer in Korean female never-smokers. Tuberc Respir Dis. 2003;54:485–494.
14. Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics. 1996;6:187–191. [PubMed]
15. Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N, Ino T, Utsunomiya A, Maruta A, Jin-nai I, Kamada N, Kubota Y, Nakamura H, Shimazaki C, Horiike S, Kodera Y, Saito H, Ueda R, Wiemels J, Ohno R. Analysis of genetic polymorphism in NQ01, GSTM1, GSTT1, and CYP3A4 in 469 Japanese patients with therapy-related leukemic/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res. 2000;6:4091–4095. [PubMed]
16. Zhang H, Ahmadi A, Arbman G, Zdolsek J, Carstensen J, Nordenskjold B, Soderkvist P, Sun XF. Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma. Int J Cancer. 1999;84:135–138. [PubMed]
17. Naveen AT, Adithan C, Padmaja N, Shashindran CH, Abraham BK, Satyanarayanamoorthy K, Anitha P, Gerard N, Krishnamoorthy R. Glutathione S-transferase M1 and T1 null genotype distribution in south Indians. Eur J Clin Pharmacol. 2004;60:403–406. [PubMed]
18. Yim JJ, Yoo CG, Lee CT, Kim YW, Han SK, Shim YS. Lack of association between glutathione S-transferase P1 polymorphism and COPD in Koreans. Lung. 2002;180:119–125. [PubMed]
19. Wang J, Deng Y, Cheng J, Ding J, Tokudome S. GST genetic poly morphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett. 2003;201:185–193. [PubMed]
20. Kihara M, Noda K. Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. Cancer Lett. 1999;137:53–60. [PubMed]
21. Schneider J, Bernges U, Philipp M, Woitowitz HJ. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett. 2004;208:65–74. [PubMed]
22. Ntais C, Polycarpou A, Ioannidis JP. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2005;14:176–181. [PubMed]
23. Vogl FD, Taioli E, Maugard C, Zheng W, Pinto LF, Ambrosone C, Parl FF, Nedelcheva-Kristensen V, Rebbeck TR, Brennan P, Boffetta P. Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev. 2004;13:1473–1479. [PubMed]
24. Smits KM, Gaspari L, Weijenberg MP, Dolzan V, Golka K, Roemer HC, Nedelcheva Kristensen V, Lechner MC, Mehling GI, Seidegard J, Strange RC, Taioli E. Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC study. Biomarkers. 2003;8:299–310. [PubMed]
25. Martin Y, Alison C, Chantelle H, Zsofia KJ, Elanie S, Rosalind E, Estella M, Daniel C, Richard H. Relationship between glutathione S-transferase M1, T1, and P1 polymorphism and chronic lymphocytic leukemia. Blood. 2002;99:4216–4218. [PubMed]
26. Kathleen ME, Qiuyin C, Shu XO, Fan J, Zhu TL, Qi D, Gao YT, Wei Z. Genetic polymorphism in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai breast cancer study and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2004;13:197–204. [PubMed]
27. Jorge G, Sonia R, Octavia MG, Lsabel M, Teresa CF, Edward L, Luzia G, Julieta EP, Jose R. Combined effects of glutathione S-transferase polymorphisms and thyroid cancer risk. Cancer Genet Cytogenet. 2004;151:60–67. [PubMed]
28. Garte S, Gspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10:1239–1248. [PubMed]
29. Jee SH, Lee JE, Kim S, Kim JH, Um SJ, Lee SJ, Namkoong SE, Park JS. GSTP1 polymorphism, cigarette smoking and cervical cancer risk in Korean women. Yonsei Med J. 2002;43:712–716. [PubMed]

Articles from Journal of Korean Medical Science are provided here courtesy of Korean Academy of Medical Sciences
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...